News & Events

Recent News

New FDA Release: PLA2R ELISA

Following the FDA clearance of anti-PLA2R IFA, EUROIMMUN US is proud to announce FDA clearance of anti-phospholipase A2 receptor (PLA2R) ELISA.

The anti-PLA2R ELISA is a complementary assay to the FDA-cleared EUROIMMUN anti-PLA2R IFA and aids in the diagnosis of primary membranous glomerulonephritis (pMGN), in conjunction with other laboratory and clinical findings.

Anti-PLA2R ELISA testing is currently offered at the following location:

Massachusetts General Hospital
A. Bernard Collins
(617) 726-8444